Stonepine Capital Management, LLC - ANI PHARMACEUTICALS INC ownership

ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 135 filers reported holding ANI PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.30 and the average weighting 0.1%.

Quarter-by-quarter ownership
Stonepine Capital Management, LLC ownership history of ANI PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$854,000
+16.5%
28,800
+10.5%
0.40%
+30.6%
Q1 2022$733,000
-69.6%
26,060
-50.2%
0.30%
-72.5%
Q4 2021$2,410,000
+4203.6%
52,290
+3069.1%
1.11%
+1575.8%
Q1 2016$56,0001,6500.07%
Other shareholders
ANI PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
MANGROVE PARTNERS IM, LLC 326,778$20,152,0002.95%
Hawk Ridge Capital Management 188,761$11,641,0001.89%
Global Alpha Capital Management Ltd. 169,746$10,468,0001.55%
Mesirow Financial Investment Management, Inc. 5,723$353,0001.49%
1492 Capital Management LLC 25,093$1,547,0001.37%
THB ASSET MANAGEMENT 91,018$5,613,0001.04%
Regent Investment Management LLC 41,329$2,549,0000.78%
Phocas Financial Corp. 101,567$6,263,0000.75%
INVESTMENT COUNSELORS OF MARYLAND LLC 284,334$17,535,0000.75%
HUSSMAN STRATEGIC ADVISORS, INC. 35,500$2,189,0000.70%
View complete list of ANI PHARMACEUTICALS INC shareholders